Source: Guideline 1999



Rating:

Share or cite this content

Citations should be made in the following way:
U. Costabel, G.W. Hunninghake, on behalf of the Sarcoidosis Statement Committee. ATS/ERS/WASOG statement on sarcoidosis. Guideline 1999

Member's Comments

No comment yet.

Related content which might interest you: Diagnosis and treatment of sarcoidosis in Tatarstan Republic: the influence of 'ATS/ERS/WASOG statement on sarcoidosis' Source: Eur Respir J 2003; 22: Suppl. 45, 234s Year: 2003 WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension Source: Eur Respir Rev, 31 (163) 210165; 10.1183/16000617.0165-2021 Year: 2022 International consensus statement on idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 17: 163-167 Year: 2001 An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features Source: Eur Respir J 2015; 46: 976-987 Year: 2015 European Respiratory Society statement: diagnosis and treatment of pulmonary disease in a1-antitrypsin deficiency Source: Eur Respir J, 50 (5) 1700610; 10.1183/13993003.00610-2017 Year: 2017 European Respiratory Society statement: diagnosis and treatment of pulmonary disease in a1-antitrypsin deficiency Source: Guideline 2017 Year: 2017 The critical statement of the asthma expert Source: Annual Congress 2012 - Endo meets obstruction: the new endoscopic treatment options for obstructive lung diseases Year: 2012 Pulmonary rehabilitation: a summary of the 2016 ATS/ERS policy statement Source: International Congress 2016 – New statement on pulmonary rehabilitation Year: 2016 ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias Source: Eur Respir J 2002; 19: 794-796 Year: 2002 ERS/EAACI statement on adherence to international adult asthma guidelines Source: Virtual Congress 2021 – ERS/EAACI statement on adherence to international adult asthma guidelines Year: 2021 ERS/EAACI statement on adherence to international adult asthma guidelines Source: Eur Respir Rev, 30 (161) 210132; 10.1183/16000617.0132-2021 Year: 2021 European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis Source: Eur Respir J 2010; 35: 14-26 Year: 2010 An official European Respiratory Society statement on physical activity in COPD Source: Guideline 2014 Year: 2014 An official European Respiratory Society statement on physical activity in COPD Source: Eur Respir J 2014; 44: 1521-1537 Year: 2014 Guideline methodology in the ERS/ATS COPD exacerbation guidelines Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention Year: 2013 International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Source: Eur Respir J 2014; 43: 343-373 Year: 2013 International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Source: ERS Webinar 2020: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Year: 2020